MedTech Frontiers - How Data and Open Source Will Transform Health
How MedTech Companies Get Paid: Understanding Reimbursement Basics and How Startups Successfully...
11
How MedTech Companies Get Paid Understanding reimbursement basics and how startups successfully navigate the US medical system
-
date post
14-Sep-2014 -
Category
Economy & Finance
-
view
245 -
download
0
description
Join Zack Miller, Head of the Investor Community at OurCrowd, and Fauzea Hussain, VP of Avalere Health, a leading advisory company focused on healthcare business strategy and public policy, as they address the opportunities and challenges of reimbursement in the MedTech industry. When we invest in a medtech startup, investors frequently ask about the probability of getting a device approved and reimbursed for in the US. Join us to learn about: Reimbursement basics: what is coding, coverage and payment? Differences by setting of care: devices to be used inpatient vs devices to be used outpatient Trends in collection of evidence and health economic data ACA (Obamacare) trends relevant for medical device manufacturers
Transcript of How MedTech Companies Get Paid: Understanding Reimbursement Basics and How Startups Successfully...
How MedTech
Companies Get Paid
Understanding reimbursement basics and how
startups successfully navigate the US medical
system
Your Hosts
Zack Miller Partner, Investor community
OurCrowd
Fauzea HussainVice President
Avalere Health
Avalere Health /
2014 Outlook
March 2014
avalerehealth.net
Avalere Provides A Comprehensive Perspective
Through our engagement with every sector of the healthcare
marketplace, we can support your business goals in an increasingly
integrated and financially-constrained environment.
Healthcare Reform Increases Covered Lives and Focuses on
Shifting Incentives in Care Delivery
FEE-FOR-SERVICE (FFS) – THE TRADITIONAL APPROACH TO PAYMENT –
VIEWED AS INSUFFICIENT AT CONTAINING COSTS
PAST:
Rewards Volume
FUTURE:
Rewards Quality and
Efficiency
• Siloed FFS
• Volume-based
rewards
• Limited coordination
or shared risk
• Value-based purchasing
• Public reporting
• Bundled payments
• Direct link between
payment and outcomes
• Greater focus on care
coordination and
prevention
Historical Paradigm
Research & Development Commercial
Development
Commercialization
Inline
PRODUCT LIFE CYCLE
New Paradigm Required
Development
Commercialization
Inline
PRODUCT LIFE CYCLE
Commercial
Research & Development
Connect with Avalere
For more information /Please contact:
Debbie Garner | EMEA Regional Director
+972-54-945-6260
Fauzea Hussain | Vice President Reimbursement and
Product Commercialization
202-207-3802
’s MedTech portfolio companies
Zack Miller
OurCrowd
+972-2-636-9000
+1-917-617-1026
www.ourcrowd.com
Fauzea Hussain
Avalere Health
+1-202-207-3802
www.avalerehealth.net
Thanks for joining us!
